Donor CD8 T cells and IFN-γ are critical for sex-based differences in donor CD4 T cell engraftment and lupus-like phenotype in short-term chronic graft-versus-host disease mice

Journal of Immunology

Volumn 186, Issue 11, 2011, Pages 6238-6254

  Foster, Anthony D ^a   Soloviova, Kateryna ^a   Puliaeva, Irina ^a   Puliaiev, Maksym ^a   Puliaev, Roman ^a   Finkelman, Fred ^b   Via, Charles S ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENGRAFTMENT; FEMALE; GRAFT REJECTION; HOMEOSTASIS; IN VIVO STUDY; LUPUS LIKE SYNDROME; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL TRANSPLANTATION; CHRONIC DISEASE; CYTOKINES; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HOST VS GRAFT REACTION; INTERFERON-GAMMA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED DBA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX FACTORS; TIME FACTORS;

EID: 79958077308     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001074     Document Type: Article

References (31)

1. McCarty, D. J., S. Manzi, T. A. Medsger, Jr., R. Ramsey-Goldman, R. E. LaPorte, and C. K. Kwoh. 1995. Incidence of systemic lupus erythematosus: race and gender differences. Arthritis Rheum. 38: 1260-1270.
2. Lahita, R. G. 1986. The influence of sex hormones on the disease systemic lupus erythematosus. Springer Semin. Immunopathol. 9: 305-314.
3. Gleichmann, E., and H. Gleichmann. 1985. Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases. J. Invest. Dermatol. 85: 115s-120s.
4. Eisenberg, R. 2003. The chronic graft-versus-host model of systemic autoimmunity. Curr. Dir. Autoimmun. 6: 228-244.
5. Rolink, A. G., and E. Gleichmann. 1983. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes. J. Exp. Med. 158: 546-558.
6. Morris, S. C., P. L. Cohen, and R. A. Eisenberg. 1990. Experimental induction of systemic lupus erythematosus by recognition of foreign Ia. Clin. Immunol. Immunopathol. 57: 263-273.
7. Morris, S. C., R. L. Cheek, P. L. Cohen, and R. A. Eisenberg. 1990. Autoantibodies in chronic graft versus host result from cognate T-B interactions. J. Exp. Med. 171: 503-517.
8. Lang, T. J., P. Nguyen, J. C. Papadimitriou, and C. S. Via. 2003. Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells. J. Immunol. 171: 5795-5801.
9. van Rappard-van der Veen, F. M., A. G. Rolink, and E. Gleichmann. 1982. Diseases caused by reactions of T lymphocytes towards incompatible structures of the major histocompatibility complex. VI. Autoantibodies characteristic of systemic lupus erythematosus induced by abnormal T-B cell cooperation across I-E. J. Exp. Med. 155: 1555-1560.
10. Van Rappard-Van Der Veen, F. M., T. Radaszkiewicz, L. Terraneo, and E. Gleichmann. 1983. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different non-irradiated F1 mice. J. Immunol. 130: 2693-2701. (Pubitemid 13107693)
11. Grader-Beck, T., L. Casciola-Rosen, T. J. Lang, R. Puliaev, A. Rosen, and C. S. Via. 2007. Apoptotic splenocytes drive the autoimmune response to poly (ADP-ribose) polymerase 1 in a murine model of lupus. J. Immunol. 178: 95-102.
12. Via, C. S., and G. M. Shearer. 1988. Murine graft-versus-host disease as a model for the development of autoimmunity: relevance of cytotoxic T lymphocytes. Ann. N. Y. Acad. Sci. 532: 44-50.
13. Puliaeva, I., R. Puliaev, A. Shustov, M. Haas, and C. S. Via. 2008. Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T cell responses but not for T cell-dependent B cell responses. J. Immunol. 181: 5912-5929.
14. Foster, A. D., M. Haas, I. Puliaeva, K. Soloviova, R. Puliaev, and C. S. Via. 2010. Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression. Clin. Immunol. 136: 61-73.
15. Gerdes, J., L. Li, C. Schlueter, M. Duchrow, C. Wohlenberg, C. Gerlach, I. Stahmer, S. Kloth, E. Brandt, and H. D. Flad. 1991. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol. 138: 867-873.
16. Puliaev, R., I. Puliaeva, L. A. Welniak, A. E. Ryan, M. Haas, W. J. Murphy, and C. S. Via. 2008. CTL-promoting effects of CD40 stimulation outweigh B cellstimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus. J. Immunol. 181: 47-61.
17. Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78.
18. Xiao, Z., K. A. Casey, S. C. Jameson, J. M. Curtsinger, and M. F. Mescher. 2009. Programming for CD8 T cell memory development requires IL-12 or type I IFN. J. Immunol. 182: 2786-2794.
19. Spolski, R., and W. J. Leonard. 2008. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26: 57-79.
20. Shustov, A., P. Nguyen, F. Finkelman, K. B. Elkon, and C. S. Via. 1998. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production. J. Immunol. 161: 2848-2855.
21. Puliaev, R., P. Nguyen, F. D. Finkelman, and C. S. Via. 2004. Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease. J. Immunol. 173: 910-919.
22. Puliaeva, I., K. Soloviova, M. Puliaiev, T. Lang, R. Puliaev, and C. S. Via. 2011. Enhancement of suboptimal CD8 cytotoxic T cell effector function in vivo using antigen-specific CD80 defective T cells. J. Immunol. 186: 291-304.
23. Via, C. S., A. Shustov, V. Rus, T. Lang, P. Nguyen, and F. D. Finkelman. 2001. In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL. J. Immunol. 167: 6821-6826.
24. Horwitz, D. A., W. Stohl, and J. D. Gray. 2002. T lymphocytes, natural killer cells and immune regulation. In Dubois' Lupus Erythematosus. D. J. Wallace, and B. H. Hahn, eds., eds. Lippincott Williams & Wilkins, Philadelphia, p. 157-185.
25. Yokota, S., T. D. Geppert, and P. E. Lipsky. 1988. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha. J. Immunol. 140: 531-536.
26. Brown, G. R., E. L. Lee, and D. L. Thiele. 2003. TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms. J. Immunol. 170: 5082-5088.
27. Shustov, A., I. Luzina, P. Nguyen, J. C. Papadimitriou, B. Handwerger, K. B. Elkon, and C. S. Via. 2000. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. J. Clin. Invest. 106: R39-R47.
28. Via, C. S., S. O. Sharrow, and G. M. Shearer. 1987. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J. Immunol. 139: 1840-1849.
29. Tschetter, J. R., E. Mozes, and G. M. Shearer. 2000. Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J. Immunol. 165: 5987-5994.
30. De Wit, D., M. Van Mechelen, C. Zanin, J. M. Doutrelepont, T. Velu, C. Gérard, D. Abramowicz, J. P. Scheerlinck, P. De Baetselier, J. Urbain, et al. 1993. Preferential activation of Th2 cells in chronic graft-versus-host reaction. J. Immunol. 150: 361-366. (Pubitemid 23133610)
31. Puliaeva, I., R. Puliaev, and C. S. Via. 2009. Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE. Autoimmun. Rev. 8: 219-223.